How about rather than using these vague negative swipes for your own self-interest, you try talking to the data presented. You are suggesting that 60% reduction in mortality is a poor result? Show me your research on this and the current treatment landscape.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-95
-
- There are more pages in this discussion • 928 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.000(0.00%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $1.58 | $1.41 | $36.50K | 23.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 3000 | 1 |
View Market Depth
| Last trade - 09.40am 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable